These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6596820

  • 21. [A new UV-B irradiation unit. Experiences with psoriasis vulgaris with low dosage UV-B irradiation and local cignoline use].
    Galosi A, Dorn M, Przybilla B.
    Z Hautkr; 1985 Dec 15; 60(24):1929-30, 1935-6, 1939. PubMed ID: 4096060
    [Abstract] [Full Text] [Related]

  • 22. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM, Kolari PJ, Mustakallio KK.
    Acta Derm Venereol; 1984 Dec 15; 64(2):134-9. PubMed ID: 6203301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen.
    Runne U, Kunze J.
    Br J Dermatol; 1982 Feb 15; 106(2):135-9. PubMed ID: 7059509
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Selective phototherapy (SUP) and cygnoline in the treatment of psoriasis].
    Nowak A, Kadyków M, Zalewska-Kubicka L.
    Przegl Dermatol; 1983 Feb 15; 70(4):403-12. PubMed ID: 6366920
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
    Sminkels OQ, Prins M, Veeniiuis RT, De Boo T, Gerritsen MJ, Van Der Wilt GJ, Van De Kerkhof PC, Van Der Valk PG.
    Eur J Dermatol; 2004 Feb 15; 14(3):159-65. PubMed ID: 15246941
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
    de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM.
    Dermatology; 2010 Feb 15; 220(4):329-32. PubMed ID: 20389024
    [Abstract] [Full Text] [Related]

  • 31. [Dithranol and combined treatment procedures: pro and con].
    Mahrle G, Schulze HJ, Steigleder GK.
    Hautarzt; 1985 Jan 15; 36(1):34-9. PubMed ID: 3972577
    [Abstract] [Full Text] [Related]

  • 32. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
    Schaefer H, Farber EM, Goldberg L, Schalla W.
    Br J Dermatol; 1980 May 15; 102(5):571-3. PubMed ID: 7387901
    [Abstract] [Full Text] [Related]

  • 33. Short-contact modification of the Ingram regime.
    Ryatt KS, Statham BN, Rowell NR.
    Br J Dermatol; 1984 Oct 15; 111(4):455-9. PubMed ID: 6487547
    [Abstract] [Full Text] [Related]

  • 34. Short-contact treatment at home with Micanol.
    Volden G, Björnberg A, Tegner E, Pedersen NB, Arlés UB, Agren S, Brolund L.
    Acta Derm Venereol Suppl (Stockh); 1992 Oct 15; 172():20-2. PubMed ID: 1585757
    [Abstract] [Full Text] [Related]

  • 35. A comparison of Antraderm stick 1% and 2% with dithranol paste 0.25% and 0.5% respectively in the treatment of psoriasis.
    Eilard U, Edin L.
    Br J Clin Pract; 1985 Jun 15; 39(6):232-4. PubMed ID: 4041349
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of tar and dithranol on fibrinolysis in treatment of psoriasis].
    Arenberger P, Buchtová L.
    Dermatol Monatsschr; 1990 Jun 15; 176(11):699-700. PubMed ID: 2083610
    [Abstract] [Full Text] [Related]

  • 37. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
    Göring HD, Voss M.
    Hautarzt; 1984 Mar 15; 35(3):148-51. PubMed ID: 6715170
    [Abstract] [Full Text] [Related]

  • 38. [Potential factors influencing dithranol erythema].
    Richter G, Barth J.
    Dermatol Monatsschr; 1986 Mar 15; 172(5):272-5. PubMed ID: 3721033
    [No Abstract] [Full Text] [Related]

  • 39. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H, Mustakallio KK.
    Acta Derm Venereol; 1983 Mar 15; 63(3):237-40. PubMed ID: 6192640
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.